Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New Ebola virus discovered in Sierra Leone
The latest Ebola outbreak in 2013-2016 killed more than 11,000 people in West Africa.

Bombali virus ‘has the potential to infect human cells’

Scientists have discovered a new Ebola virus in free-tailed bats in Sierra Leone, providing the strongest evidence yet that bats are the natural hosts of these viruses.

The new virus, Bombali virus, has the potential to infect human cells, researchers say, but it is not yet known whether it has infected people, or whether it is harmful.

It was discovered in insectivorous bats roosting in people’s homes, as part of the PREDICT Ebola Host Project.

Bombali virus is not the strain that caused the 2013-2016 Ebola outbreak, which killed more than 11,000 people in West Africa.

Despite more than 40 years of research, it is still not known where these viruses ‘hide’ between human outbreaks, which makes outbreak prevention a challenge.

Professor Aiah Gbakima, honourable minister of technical and higher education in Sierra Leone, said: “The Ebola virus outbreak in 2013-2016 devastated local communities here in Sierra Leone.

“It is critically important to understand more about where these viruses come from and what causes them to spill over into humans.

"There is still much to do to understand the transmission dynamics of Ebola virus, but the discovery of Bombali virus in bats is an important step in the right direction.”

Image © Scientific Animations (CC BY-SA 4.0)

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.